ID   HXB13_HUMAN             Reviewed;         284 AA.
AC   Q92826; B2R878; Q96QM4; Q99810;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   07-APR-2021, entry version 189.
DE   RecName: Full=Homeobox protein Hox-B13;
GN   Name=HOXB13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8756292;
RA   Zeltser L.M., Desplan C., Heintz N.;
RT   "Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains
RT   colinearity.";
RL   Development 122:2475-2484(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9665387; DOI=10.1046/j.1523-1747.1998.00238.x;
RA   Stelnicki E.J., Arbeit J., Cass D.L., Saner C., Harrison M., Largman C.;
RT   "Modulation of the human homeobox genes PRX-2 and HOXB13 in scarless fetal
RT   wounds.";
RL   J. Invest. Dermatol. 111:57-63(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7] {ECO:0007744|PDB:2CRA}
RP   STRUCTURE BY NMR OF 217-273.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain of human homeo box B13.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [8] {ECO:0007744|PDB:5EDN, ECO:0007744|PDB:5EEA, ECO:0007744|PDB:5EG0}
RP   X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 209-284 IN COMPLEX WITH MEIS2 AND
RP   DNA, SUBUNIT, AND DNA-BINDING.
RA   Morgunova E., Yin Y., Jolma A., Popov A., Taipale J.;
RT   "Molecular basis of recognition of two distinct DNA sequences by a single
RT   transcription factor.";
RL   Submitted (OCT-2015) to the PDB data bank.
RN   [9] {ECO:0007744|PDB:5EF6, ECO:0007744|PDB:5EGO}
RP   X-RAY CRYSTALLOGRAPHY (2.54 ANGSTROMS) OF 217-278 IN COMPLEX WITH MEIS1 AND
RP   METHYLATED DNA, SUBUNIT, AND DNA-BINDING.
RX   PubMed=28473536; DOI=10.1126/science.aaj2239;
RA   Yin Y., Morgunova E., Jolma A., Kaasinen E., Sahu B., Khund-Sayeed S.,
RA   Das P.K., Kivioja T., Dave K., Zhong F., Nitta K.R., Taipale M., Popov A.,
RA   Ginno P.A., Domcke S., Yan J., Schubeler D., Vinson C., Taipale J.;
RT   "Impact of cytosine methylation on DNA binding specificities of human
RT   transcription factors.";
RL   Science 356:0-0(2017).
RN   [10]
RP   VARIANT MET-41.
RX   PubMed=11857506; DOI=10.1002/tera.10009;
RA   Kosaki K., Kosaki R., Suzuki T., Yoshihashi H., Takahashi T., Sasaki K.,
RA   Tomita M., McGinnis W., Matsuo N.;
RT   "Complete mutation analysis panel of the 39 human HOX genes.";
RL   Teratology 65:50-62(2002).
RN   [11]
RP   VARIANT PC GLU-84.
RX   PubMed=22714738; DOI=10.1158/1055-9965.epi-12-0495;
RA   Breyer J.P., Avritt T.G., McReynolds K.M., Dupont W.D., Smith J.R.;
RT   "Confirmation of the HOXB13 G84E germline mutation in familial prostate
RT   cancer.";
RL   Cancer Epidemiol. Biomarkers Prev. 21:1348-1353(2012).
RN   [12]
RP   INVOLVEMENT IN PC, VARIANT PC GLU-84, AND VARIANTS ASP-88; PRO-144; CYS-216
RP   AND GLY-229.
RX   PubMed=22236224; DOI=10.1056/nejmoa1110000;
RA   Ewing C.M., Ray A.M., Lange E.M., Zuhlke K.A., Robbins C.M., Tembe W.D.,
RA   Wiley K.E., Isaacs S.D., Johng D., Wang Y., Bizon C., Yan G., Gielzak M.,
RA   Partin A.W., Shanmugam V., Izatt T., Sinari S., Craig D.W., Zheng S.L.,
RA   Walsh P.C., Montie J.E., Xu J., Carpten J.D., Isaacs W.B., Cooney K.A.;
RT   "Germline mutations in HOXB13 and prostate-cancer risk.";
RL   N. Engl. J. Med. 366:141-149(2012).
RN   [13]
RP   INVOLVEMENT IN PC, AND VARIANT PC GLU-84.
RX   PubMed=23292082; DOI=10.1158/1055-9965.epi-12-1000-t;
RA   Laitinen V.H., Wahlfors T., Saaristo L., Rantapero T., Pelttari L.M.,
RA   Kilpivaara O., Laasanen S.L., Kallioniemi A., Nevanlinna H., Aaltonen L.,
RA   Vessella R.L., Auvinen A., Visakorpi T., Tammela T.L., Schleutker J.;
RT   "HOXB13 G84E mutation in Finland: population-based analysis of prostate,
RT   breast, and colorectal cancer risk.";
RL   Cancer Epidemiol. Biomarkers Prev. 22:452-460(2013).
RN   [14]
RP   INVOLVEMENT IN PC, AND VARIANT PC GLU-84.
RX   PubMed=23064873; DOI=10.1007/s00439-012-1229-4;
RG   International Consortium for Prostate Cancer Genetics;
RA   Xu J., Lange E.M., Lu L., Zheng S.L., Wang Z., Thibodeau S.N.,
RA   Cannon-Albright L.A., Teerlink C.C., Camp N.J., Johnson A.M., Zuhlke K.A.,
RA   Stanford J.L., Ostrander E.A., Wiley K.E., Isaacs S.D., Walsh P.C.,
RA   Maier C., Luedeke M., Vogel W., Schleutker J., Wahlfors T., Tammela T.,
RA   Schaid D., McDonnell S.K., DeRycke M.S., Cancel-Tassin G., Cussenot O.,
RA   Wiklund F., Gronberg H., Eeles R., Easton D., Kote-Jarai Z.,
RA   Whittemore A.S., Hsieh C.L., Giles G.G., Hopper J.L., Severi G.,
RA   Catalona W.J., Mandal D., Ledet E., Foulkes W.D., Hamel N., Mahle L.,
RA   Moller P., Powell I., Bailey-Wilson J.E., Carpten J.D., Seminara D.,
RA   Cooney K.A., Isaacs W.B.;
RT   "HOXB13 is a susceptibility gene for prostate cancer: results from the
RT   international consortium for prostate cancer genetics (ICPCG).";
RL   Hum. Genet. 132:5-14(2013).
RN   [15]
RP   INVOLVEMENT IN PC, AND VARIANT PC GLU-84.
RX   PubMed=25629170; DOI=10.1371/journal.pgen.1004930;
RA   Hoffmann T.J., Sakoda L.C., Shen L., Jorgenson E., Habel L.A., Liu J.,
RA   Kvale M.N., Asgari M.M., Banda Y., Corley D., Kushi L.H.,
RA   Quesenberry C.P. Jr., Schaefer C., Van Den Eeden S.K., Risch N.,
RA   Witte J.S.;
RT   "Imputation of the Rare HOXB13 G84E Mutation and Cancer Risk in a Large
RT   Population-Based Cohort.";
RL   PLoS Genet. 11:E1004930-E1004930(2015).
RN   [16]
RP   VARIANT PC GLU-84, AND VARIANT CYS-217.
RX   PubMed=27424772; DOI=10.1038/srep30026;
RA   Liu J., Prager-van der Smissen W.J., Schmidt M.K., Collee J.M.,
RA   Cornelissen S., Lamping R., Nieuwlaat A., Foekens J.A., Hooning M.J.,
RA   Verhoef S., van den Ouweland A.M., Hogervorst F.B., Martens J.W.,
RA   Hollestelle A.;
RT   "Recurrent HOXB13 mutations in the Dutch population do not associate with
RT   increased breast cancer risk.";
RL   Sci. Rep. 6:30026-30026(2016).
CC   -!- FUNCTION: Sequence-specific transcription factor which is part of a
CC       developmental regulatory system that provides cells with specific
CC       positional identities on the anterior-posterior axis. Binds
CC       preferentially to methylated DNA (PubMed:28473536).
CC       {ECO:0000269|PubMed:28473536}.
CC   -!- SUBUNIT: Heterodimer with MEIS1 (PubMed:28473536). Heterodimer with
CC       MEIS2 (Ref.8). {ECO:0000269|PubMed:28473536, ECO:0000269|Ref.8}.
CC   -!- INTERACTION:
CC       Q92826; Q92993: KAT5; NbExp=3; IntAct=EBI-11317274, EBI-399080;
CC       Q92826; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-11317274, EBI-11742507;
CC       Q92826; P17252: PRKCA; NbExp=3; IntAct=EBI-11317274, EBI-1383528;
CC       Q92826; Q15047-2: SETDB1; NbExp=3; IntAct=EBI-11317274, EBI-9090795;
CC       Q92826; P61981: YWHAG; NbExp=3; IntAct=EBI-11317274, EBI-359832;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in
CC       tissues of the prostate. Most prostate cancers are adenocarcinomas that
CC       develop in the acini of the prostatic ducts. Other rare histopathologic
CC       types of prostate cancer that occur in approximately 5% of patients
CC       include small cell carcinoma, mucinous carcinoma, prostatic ductal
CC       carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal
CC       cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell
CC       carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:22236224,
CC       ECO:0000269|PubMed:22714738, ECO:0000269|PubMed:23064873,
CC       ECO:0000269|PubMed:23292082, ECO:0000269|PubMed:25629170,
CC       ECO:0000269|PubMed:27424772}. Note=Disease susceptibility is associated
CC       with variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Abd-B homeobox family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U57052; AAC50664.1; -; mRNA.
DR   EMBL; U81599; AAB39863.1; -; mRNA.
DR   EMBL; BT007410; AAP36078.1; -; mRNA.
DR   EMBL; AK313266; BAG36075.1; -; mRNA.
DR   EMBL; CH471109; EAW94714.1; -; Genomic_DNA.
DR   EMBL; BC007092; AAH07092.1; -; mRNA.
DR   EMBL; BC070233; AAH70233.1; -; mRNA.
DR   CCDS; CCDS11536.1; -.
DR   RefSeq; NP_006352.2; NM_006361.5.
DR   PDB; 2CRA; NMR; -; A=217-273.
DR   PDB; 5EDN; X-ray; 3.20 A; A/B/G/J=209-284.
DR   PDB; 5EEA; X-ray; 2.19 A; A/B/G/J=217-279.
DR   PDB; 5EF6; X-ray; 3.00 A; A/B/G/J=217-278.
DR   PDB; 5EG0; X-ray; 3.10 A; B=217-277.
DR   PDB; 5EGO; X-ray; 2.54 A; B=217-277.
DR   PDB; 5NO6; X-ray; 2.88 A; A/B=217-278.
DR   PDBsum; 2CRA; -.
DR   PDBsum; 5EDN; -.
DR   PDBsum; 5EEA; -.
DR   PDBsum; 5EF6; -.
DR   PDBsum; 5EG0; -.
DR   PDBsum; 5EGO; -.
DR   PDBsum; 5NO6; -.
DR   SMR; Q92826; -.
DR   BioGRID; 115744; 15.
DR   IntAct; Q92826; 11.
DR   MINT; Q92826; -.
DR   STRING; 9606.ENSP00000290295; -.
DR   iPTMnet; Q92826; -.
DR   PhosphoSitePlus; Q92826; -.
DR   BioMuta; HOXB13; -.
DR   DMDM; 50403792; -.
DR   jPOST; Q92826; -.
DR   MassIVE; Q92826; -.
DR   MaxQB; Q92826; -.
DR   PaxDb; Q92826; -.
DR   PeptideAtlas; Q92826; -.
DR   PRIDE; Q92826; -.
DR   ProteomicsDB; 75504; -.
DR   Antibodypedia; 3837; 264 antibodies.
DR   DNASU; 10481; -.
DR   Ensembl; ENST00000290295; ENSP00000290295; ENSG00000159184.
DR   GeneID; 10481; -.
DR   KEGG; hsa:10481; -.
DR   UCSC; uc002ioa.4; human.
DR   CTD; 10481; -.
DR   DisGeNET; 10481; -.
DR   GeneCards; HOXB13; -.
DR   HGNC; HGNC:5112; HOXB13.
DR   HPA; ENSG00000159184; Group enriched (intestine, prostate).
DR   MalaCards; HOXB13; -.
DR   MIM; 176807; phenotype.
DR   MIM; 604607; gene.
DR   neXtProt; NX_Q92826; -.
DR   OpenTargets; ENSG00000159184; -.
DR   Orphanet; 1331; Familial prostate cancer.
DR   PharmGKB; PA29388; -.
DR   VEuPathDB; HostDB:ENSG00000159184.7; -.
DR   eggNOG; KOG0487; Eukaryota.
DR   GeneTree; ENSGT00940000159029; -.
DR   HOGENOM; CLU_059940_1_0_1; -.
DR   InParanoid; Q92826; -.
DR   OMA; DSSAQHP; -.
DR   OrthoDB; 1190384at2759; -.
DR   PhylomeDB; Q92826; -.
DR   TreeFam; TF330813; -.
DR   PathwayCommons; Q92826; -.
DR   SIGNOR; Q92826; -.
DR   BioGRID-ORCS; 10481; 28 hits in 1010 CRISPR screens.
DR   ChiTaRS; HOXB13; human.
DR   EvolutionaryTrace; Q92826; -.
DR   GeneWiki; HOXB13; -.
DR   GenomeRNAi; 10481; -.
DR   Pharos; Q92826; Tbio.
DR   PRO; PR:Q92826; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q92826; protein.
DR   Bgee; ENSG00000159184; Expressed in prostate gland and 34 other tissues.
DR   Genevisible; Q92826; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005667; C:transcription regulator complex; IEA:Ensembl.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0008327; F:methyl-CpG binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0060743; P:epithelial cell maturation involved in prostate gland development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl.
DR   GO; GO:0040008; P:regulation of growth; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0033574; P:response to testosterone; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; TAS:ProtInc.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR022067; HoxA13_N.
DR   Pfam; PF00046; Homeodomain; 1.
DR   Pfam; PF12284; HoxA13_N; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Developmental protein; Disease variant; DNA-binding;
KW   Homeobox; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..284
FT                   /note="Homeobox protein Hox-B13"
FT                   /id="PRO_0000200160"
FT   DNA_BIND        216..275
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108"
FT   REGION          217..246
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000305|PubMed:28473536, ECO:0000305|Ref.8"
FT   REGION          258..269
FT                   /note="Interaction with 5-mCpG DNA"
FT                   /evidence="ECO:0000305|PubMed:28473536"
FT   REGION          270..273
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000305|PubMed:28473536, ECO:0000305|Ref.8"
FT   VARIANT         41
FT                   /note="T -> M (in dbSNP:rs199799743)"
FT                   /evidence="ECO:0000269|PubMed:11857506"
FT                   /id="VAR_031849"
FT   VARIANT         84
FT                   /note="G -> E (in PC; rare variant associated with disease
FT                   susceptibility; dbSNP:rs138213197)"
FT                   /evidence="ECO:0000269|PubMed:22236224,
FT                   ECO:0000269|PubMed:22714738, ECO:0000269|PubMed:23064873,
FT                   ECO:0000269|PubMed:23292082, ECO:0000269|PubMed:25629170,
FT                   ECO:0000269|PubMed:27424772"
FT                   /id="VAR_071866"
FT   VARIANT         88
FT                   /note="Y -> D (found in prostate cancer samples; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:22236224"
FT                   /id="VAR_071867"
FT   VARIANT         144
FT                   /note="L -> P (found in prostate cancer samples; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:22236224"
FT                   /id="VAR_071868"
FT   VARIANT         216
FT                   /note="G -> C (found in prostate cancer samples; unknown
FT                   pathological significance; dbSNP:rs375917549)"
FT                   /evidence="ECO:0000269|PubMed:22236224"
FT                   /id="VAR_071869"
FT   VARIANT         217
FT                   /note="R -> C (in dbSNP:rs139475791)"
FT                   /evidence="ECO:0000269|PubMed:27424772"
FT                   /id="VAR_077246"
FT   VARIANT         229
FT                   /note="R -> G (found in prostate cancer samples; unknown
FT                   pathological significance; dbSNP:rs529100627)"
FT                   /evidence="ECO:0000269|PubMed:22236224"
FT                   /id="VAR_071870"
FT   CONFLICT        138..139
FT                   /note="QP -> HA (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211
FT                   /note="C -> S (in Ref. 1; AAC50664)"
FT                   /evidence="ECO:0000305"
FT   HELIX           225..237
FT                   /evidence="ECO:0007744|PDB:5EEA"
FT   HELIX           243..253
FT                   /evidence="ECO:0007744|PDB:5EEA"
FT   HELIX           257..275
FT                   /evidence="ECO:0007744|PDB:5EEA"
SQ   SEQUENCE   284 AA;  30676 MW;  3EE5898449C33CFE CRC64;
     MEPGNYATLD GAKDIEGLLG AGGGRNLVAH SPLTSHPAAP TLMPAVNYAP LDLPGSAEPP
     KQCHPCPGVP QGTSPAPVPY GYFGGGYYSC RVSRSSLKPC AQAATLAAYP AETPTAGEEY
     PSRPTEFAFY PGYPGTYQPM ASYLDVSVVQ TLGAPGEPRH DSLLPVDSYQ SWALAGGWNS
     QMCCQGEQNP PGPFWKAAFA DSSGQHPPDA CAFRRGRKKR IPYSKGQLRE LEREYAANKF
     ITKDKRRKIS AATSLSERQI TIWFQNRRVK EKKVLAKVKN SATP
//
